Nautilus Biotechnology In... (NAUT)
undefined
undefined%
At close: undefined
2.00
2.05%
After-hours Dec 13, 2024, 04:26 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue 5.71M 3.42M 2.84M 2.35M - -
Gross Profit -5.71M -3.42M -2.84M -2.35M - -
Operating Income -76.15M -63.62M -50.50M -15.74M -10.11K -111.68M
Interest Income 12.55M 5.82M 329.00K - - -
Pretax Income -63.67M -57.92M -50.31M -15.62M -9.62K 626.60M
Net Income -63.67M -63.74M -50.31M -15.62M -9.62K 626.60M
Selling & General & Admin 28.90M 25.95M 21.15M 3.31M 1.62K 111.68M
Research & Development 47.25M 37.67M 29.35M 12.43M 8.49K -
Other Expenses - -122.00K 183.00K 125.00K - -
Operating Expenses 76.15M 63.62M 50.50M 15.74M 9.62K 111.68M
Interest Expense - 5.82M - - - -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 76.15M 63.62M 50.50M 15.74M 9.62K 111.68M
Income Tax - 5.82M 2.61M 2.14M -171.31K 738.12M
Shares Outstanding (Basic) 124.92M 124.59M 84.46M 29.96M 7.19M 7.19M
Shares Outstanding (Diluted) 124.92M 124.59M 84.46M 29.96M 7.19M 7.19M
EPS (Basic) -0.51 -0.51 -0.6 -0.52 -0.00 87.18
EPS (Diluted) -0.51 -0.51 -0.6 -0.52 -0.00 87.18
EBITDA -74.30M -54.51M -47.47M -13.27M -9.56M 626.60M
Depreciation & Amortization 1.85M 3.42M 2.84M 2.35M 548.00K 738.28M